• 1
    Beisiegel U 1995 Receptors for triglyceride-rich lipoproteins and their role in lipoprotein metabolism. Curr Opin Lipidol 6: 117122.
  • 2
    Rohlmann A, Gotthardt M, Hammer RE, Herz J 1998 Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. J Clin Invest 101: 689695.
  • 3
    Karpe F, Humphreys SM, Samra JS, Summers LK, Frayn KN 1997 Clearance of lipoprotein remnant particles in adipose tissue and muscle in humans. J Lipid Res 38: 23352343.
  • 4
    Niemeier A, Gafvels M, Heeren J, Meyer N, Angelin B, Beisiegel U 1996 VLDL receptor mediates the uptake of human chylomicron remnants in vitro. J Lipid Res 37: 17331742.
  • 5
    Tacken PJ, Teusink B, Jong MC, Harats D, Havekes LM, van Dijk KW, Hofker MH 2000 LDL receptor deficiency unmasks altered VLDL triglyceride metabolism in VLDL receptor transgenic and knockout mice. J Lipid Res 41: 20552062.
  • 6
    Mamotte CD, Sturm M, Foo JI, van Bockxmeer FM, Taylor RR 1999 Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes. Am J Physiol 276: E553E557.
  • 7
    Mahley RW, Huang Y 1999 Apolipoprotein E: From atherosclerosis to Alzheimer's disease and beyond. Curr Opin Lipidol 10: 207217.
  • 8
    Bohnet K, Pillot T, Visvikis S, Sabolovic N, Siest G 1996 Apolipoprotein (apo) E genotype and apoE concentration determine binding of normal very low density lipoproteins to HepG2 cell surface receptors. J Lipid Res 37: 13161324.
  • 9
    Weintraub MS, Eisenberg S, Breslow JL 1987 Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 80: 15711577.
  • 10
    Shiraki M, Shiraki Y, Aoki C, Hosoi T, Inoue S, Kaneki M, Ouchi Y 1997 Association of bone mineral density with apolipoprotein E phenotype. J Bone Miner Res 12: 14381445.
  • 11
    Dick IM, Devine A, Marangou A, Dhaliwal SS, Laws S, Martins RN, Prince RL 2002 Apolipoprotein E4 is associated with reduced calcaneal quantitative ultrasound measurements and bone mineral density in elderly women. Bone 31: 497502.
  • 12
    Kohlmeier M, Saupe J, Schaefer K, Asmus G 1998 Bone fracture history and prospective bone fracture risk of hemodialysis patients are related to apolipoprotein E genotype. Calcif Tissue Int 62: 278281.
  • 13
    von Muhlen DG, Barrett-Connor E, Schneider DL, Morin PA, Parry P 2001 Osteoporosis and apolipoprotein E genotype in older adults: The Rancho Bernardo study. Osteoporos Int 12: 332335.
  • 14
    Sennels HP, Sand JC, Madsen B, Lauritzen JB, Fenger M, Jorgensen HL 2003 Association between polymorphisms of apolipoprotein E, bone mineral density of the lower forearm, quantitative ultrasound of the calcaneus and osteoporotic fractures in postmenopausal women with hip or lower forearm fracture. Scand J Clin Lab Invest 63: 247258.
  • 15
    Beisiegel U, Weber W, Bengtsson-Olivecrona G 1991 Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc Natl Acad Sci USA 88: 83428346.
  • 16
    Heeren J, Niemeier A, Merkel M, Beisiegel U 2002 Endothelial-derived lipoprotein lipase is bound to postprandial triglyceride-rich lipoproteins and mediates their hepatic clearance in vivo. J Mol Med 80: 576584.
  • 17
    Watkins BA, Li Y, Seifert MF 2001 Lipids as modulators of bone remodelling. Curr Opin Clin Nutr Metab Care 4: 105110.
  • 18
    Haddad JG, Matsuoka LY, Hollis BW, Hu YZ, Wortsman J 1993 Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest 91: 25522555.
  • 19
    Blomhoff R, Green MH, Berg T, Norum KR 1990 Transport and storage of vitamin A. Science 250: 399404.
  • 20
    Lamon-Fava S, Sadowski JA, Davidson KW, O'Brien ME, McNamara JR, Schaefer EJ 1998 Plasma lipoproteins as carriers of phylloquinone (vitamin K1) in humans. Am J Clin Nutr 67: 12261231.
  • 21
    Pan LC, Price PA 1985 The propeptide of rat bone gamma-carboxyglutamic acid protein shares homology with other vitamin K-dependent protein precursors. Proc Natl Acad Sci USA 82: 61096113.
  • 22
    Shearer MJ 2000 Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Curr Opin Clin Nutr Metab Care 3: 433438.
  • 23
    Szulc P, Chapuy MC, Meunier PJ, Delmas PD 1993 Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 91: 17691774.
  • 24
    Szulc P, Chapuy MC, Meunier PJ, Delmas PD 1996 Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: A three year follow-up study. Bone 18: 487488.
  • 25
    Liu G, Peacock M 1998 Age-related changes in serum undercarboxylated osteocalcin and its relationships with bone density, bone quality, and hip fracture. Calcif Tissue Int 62: 286289.
  • 26
    Binkley NC, Krueger DC, Kawahara TN, Engelke JA, Chappell RJ, Suttie JW 2002 A high phylloquinone intake is required to achieve maximal osteocalcin gamma-carboxylation. Am J Clin Nutr 76: 10551060.
  • 27
    Binkley NC, Krueger DC, Engelke JA, Foley AL, Suttie JW 2000 Vitamin K supplementation reduces serum concentrations of under-gamma-carboxylated osteocalcin in healthy young and elderly adults. Am J Clin Nutr 72: 15231528.
  • 28
    Hussain MM, Goldberg IJ, Weisgraber KH, Mahley RW, Innerarity TL 1997 Uptake of chylomicrons by the liver, but not by the bone marrow, is modulated by lipoprotein lipase activity. Arterioscler Thromb Vasc Biol 17: 14071413.
  • 29
    Hussain MM, Mahley RW, Boyles JK, Lindquist PA, Brecht WJ, Innerarity TL 1989 Chylomicron metabolism. Chylomicron uptake by bone marrow in different animal species. J Biol Chem 264: 1793117938.
  • 30
    Hussain MM, Mahley RW, Boyles JK, Fainaru M, Brecht WJ, Lindquist PA 1989 Chylomicron-chylomicron remnant clearance by liver and bone marrow in rabbits. Factors that modify tissue-specific uptake. J Biol Chem 264: 95719582.
  • 31
    Newman P, Bonello F, Wierzbicki AS, Lumb P, Savidge GF, Shearer MJ 2002 The uptake of lipoprotein-borne phylloquinone (vitamin K1) by osteoblasts and osteoblast-like cells: Role of heparan sulfate proteoglycans and apolipoprotein E. J Bone Miner Res 17: 426433.
  • 32
    Simonsen JL, Rosada C, Serakinci N, Justesen J, Stenderup K, Rattan SI, Jensen TG, Kassem M 2002 Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 20: 592596.
  • 33
    Heeren J, Grewal T, Laatsch A, Rottke D, Rinninger F, Enrich C, Beisiegel U 2003 Recycling of apoprotein E is associated with cholesterol efflux and high density lipoprotein internalization. J Biol Chem 278: 1437014378.
  • 34
    Haroon Y, Bacon DS, Sadowski JA 1986 Liquid-chromatographic determination of vitamin K1 in plasma, with fluorometric detection. Clin Chem 32: 19251929.
  • 35
    Pettei MJ, Israel D, Levine J 1993 Serum vitamin K concentration in pediatric patients receiving total parenteral nutrition. JPEN J Parenter Enteral Nutr 17: 465467.
  • 36
    Heeren J, Weber W, Beisiegel U 1999 Intracellular processing of endocytosed triglyceride-rich lipoproteins comprises both recycling and degradation. J Cell Sci 112: 349359.
  • 37
    Takahashi S, Suzuki J, Kohno M, Oida K, Tamai T, Miyabo S, Yamamoto T, Nakai T 1995 Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase. J Biol Chem 270: 1574715754.
  • 38
    Herz J, Kowal RC, Goldstein JL, Brown MS 1990 Proteolytic processing of the 600 kd low density lipoprotein receptor-related protein (LRP) occurs in a trans-Golgi compartment. EMBO J 9: 17691776.
  • 39
    Martensen PM, Oka K, Christensen L, Rettenberger PM, Petersen HH, Christensen A, Chan L, Heegaard CW, Andreasen PA 1997 Breast carcinoma epithelial cells express a very low-density lipoprotein receptor variant lacking the O-linked glycosylation domain encoded by exon 16, but with full binding activity for serine proteinase/serpin complexes and Mr-40,000 receptor-associated protein. Eur J Biochem 248: 583591.
  • 40
    Wyne KL, Pathak K, Seabra MC, Hobbs HH 1996 Expression of the VLDL receptor in endothelial cells. Arterioscler Thromb Vasc Biol 16: 407415.
  • 41
    Oka K, Ishimura-Oka K, Chu MJ, Sullivan M, Krushkal J, Li WH, Chan L 1994 Mouse very-low-density-lipoprotein receptor (VLDLR) cDNA cloning, tissue-specific expression and evolutionary relationship with the low-density-lipoprotein receptor. Eur J Biochem 224: 975982.
  • 42
    Moestrup SK, Gliemann J, Pallesen G 1992 Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res 269: 375382.
  • 43
    Brown MS, Kovanen PT, Goldstein JL 1981 Regulation of plasma cholesterol by lipoprotein receptors. Science 212: 628635.
  • 44
    Martins IJ, Hone E, Chi C, Seydel U, Martins RN, Redgrave TG 2000 Relative roles of LDLr and LRP in the metabolism of chylomicron remnants in genetically manipulated mice. J Lipid Res 41: 205213.
  • 45
    Trommsdorff M, Gotthardt M, Hiesberger T, Shelton J, Stockinger W, Nimpf J, Hammer RE, Richardson JA, Herz J 1999 Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 97: 689701.
  • 46
    Kohlmeier M, Saupe J, Shearer MJ, Schaefer K, Asmus G 1997 Bone health of adult hemodialysis patients is related to vitamin K status. Kidney Int 51: 12181221.
  • 47
    Szulc P, Arlot M, Chapuy MC, Duboeuf F, Meunier PJ, Delmas PD 1994 Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res 9: 15911595.
  • 48
    Schilling AF, Schinke T, Muench C, Gebauer M, Priemel M, Niemeier A, Streichert T, Rueger JM, Amling M 2004 Increased bone formation in mice lacking apolipoprotein E. J Bone Miner Res 20: 274282.
  • 49
    Ducy P and others 1996 Increased bone formation in osteocalcin-deficient mice. Nature 382: 448452.
  • 50
    Koshihara Y, Hoshi K, Okawara R, Ishibashi H, Yamamoto S 2003 Vitamin K stimulates osteoblastogenesis and inhibits osteoclastogenesis in human bone marrow cell culture. J Endocrinol 176: 339348.
  • 51
    Takeuchi Y, Suzawa M, Fukumoto S, Fujita T 2000 Vitamin K(2) inhibits adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression in murine bone marrow cell cultures. Bone 27: 769776.
  • 52
    Strickland DK, Ranganathan S 2003 Diverse role of LDL receptor-related protein in the clearance of proteases and in signaling. J Thromb Haemost 1: 16631670.
  • 53
    May P, Bock HH, Herz J 2003 Integration of endocytosis and signal transduction by lipoprotein receptors. Sci STKE 2003: E12.
  • 54
    Tamai K, Semenov M, Kato Y, Spokony R, Liu C, Katsuyama Y, Hess F, Saint-Jeannet JP, He X 2000 LDL-receptor-related proteins in Wnt signal transduction. Nature 407: 530535.
  • 55
    Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Juppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML, Osteoporosis-Pseudoglioma Syndrome Collaborative Group 2001 LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107: 513523.
  • 56
    Herz J, Clouthier DE, Hammer RE 1992 LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation. Cell 71: 411421.